While clinical laboratory Quest Diagnostics (DGX) had a rough outing last week, speculators seeking a discount may want to keep DGX stock on their radar. In the trailing five sessions, the equity …
Despite Slump, Options Traders May be Seeing Something with Quest Diagnostics (DGX)
view original post